COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study

BACKGROUND: Patients with cancer are hypothesised to be at increased risk of contracting COVID-19, leading to changes in treatment pathways in those treated with systemic anti-cancer treatments (SACT). This study investigated the outcomes of patients receiving SACT to assess whether they were at gre...

Descripción completa

Detalles Bibliográficos
Autores principales: Crolley, Valerie E., Hanna, Daire, Joharatnam-Hogan, Nalinie, Chopra, Neha, Bamac, Ekin, Desai, Meera, Lam, Yuk-Chun, Dipro, Sabiq, Kanani, Ruhi, Benson, Jack, Wilson, William, Fox, Thomas A., Shiu, Kai-Keen, Forster, Martin, Bridgewater, John, Hochhauser, Daniel, Khan, Khurum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592172/
https://www.ncbi.nlm.nih.gov/pubmed/33178336
http://dx.doi.org/10.1177/1758835920971147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592172/
https://www.ncbi.nlm.nih.gov/pubmed/33178336
http://dx.doi.org/10.1177/1758835920971147

Ejemplares similares